Dupilumab Skin Barrier Function Study in Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
- Status
- COMPLETED
- Phase
- PHASE2
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE3
Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
- Status
- COMPLETED
- Phase
- PHASE3
REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
- Status
- TERMINATED
- Phase
- PHASE1
The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE4
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE3
Viral Infection in Asthma (VIA) Study
- Status
- RECRUITING
- Phase
- PHASE4
Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
- Status
- COMPLETED
- Phase
- PHASE2
Cemiplimab in AlloSCT/SOT Recipients With CSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sarilumab COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Anti-VEGF Therapy for Acute Thyroid Eye Disease
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
- Status
- RECRUITING
- Phase
- PHASE2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2